The stock's fall snapped a seven-day winning streak.

We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to ...

Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth. See why I rate CI stock a buy at current prices.

Cigna Group closed 13.60% below its 52-week high of $370.83, which the company reached on September 16th.

StockNews.com upgraded shares of The Cigna Group (NYSE:CI – Free Report) from a buy rating to a strong-buy rating in a research note released on Saturday morning. CI has been the topic of several ...

analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Cigna Group compared to the ...

Cigna Group (NYSE:CI) made a decisive move to bolster its leadership in Asia Pacific with the appointment of Rob Peat as CEO, effective April 2025, focusing on growth acceleration across key regions.

In addition, investors have expressed worries over the company’s performance shortfalls ... BofA Securities believes that The Cigna Group (NYSE:CI) stock’s current value may restrict ...

While Cigna has demonstrated flexibility in adapting to regulatory shifts, significant changes to PBM practices could materially impact the company’s operations and financial performance.

Revenue Growth: Cigna Group's remarkable performance in 3 months is evident ... defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company ...

While Cigna has demonstrated flexibility in adapting to regulatory shifts, significant changes to PBM practices could materially impact the company’s operations and financial performance ...